Literature DB >> 1749304

Interaction between cytostatics and nutrients.

R Henriksson1, K O Rogo, K Grankvist.   

Abstract

Cancer patients have the highest prevalence of malnutrition of any group of hospitalized patients. The presence of the tumor alone may lead to reduced intake of different nutrients and treatment modalities such as surgery, chemotherapy and radiation therapy may further exacerbate nutritional disturbances. Dietary manipulation in experimental systems has shown improvement of tumor response to cancer therapy. Drug pharmacokinetics has been shown to be altered by changes in nutritional delivery. This article reviews the present knowledge, from experimental and clinical standpoints, of the potential role of different nutritional factors on the specific cancer treatment. It is obvious that alteration of at least some dietary factors affect the outcome of different forms of cancer treatment. Indeed, although interest in the clinical significance of optimal dietary intake and supplementation during cancer therapy so far remain marginal, accumulating data indicate that this area deserves further research attention.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1749304     DOI: 10.1007/bf02988858

Source DB:  PubMed          Journal:  Med Oncol Tumor Pharmacother        ISSN: 0736-0118


  59 in total

1.  Enhancement of the antitumor effect of 1,3-bis(2-chloroethyl)-1-nitrosourea by various psychotropic drugs in combination with caffeine.

Authors:  M H Cohen
Journal:  J Pharmacol Exp Ther       Date:  1975-09       Impact factor: 4.030

Review 2.  The effect of food on drug bioavailability.

Authors:  R D Toothaker; P G Welling
Journal:  Annu Rev Pharmacol Toxicol       Date:  1980       Impact factor: 13.820

3.  Toxicity, radiation sensitivity modification, and combined drug effects of ascorbic acid with misonidazole in vivo on FSaII murine fibrosarcomas.

Authors:  P Okunieff; H D Suit
Journal:  J Natl Cancer Inst       Date:  1987-08       Impact factor: 13.506

4.  Prevention of irradiation-induced bowel discomfort by sucralfate: a double-blind, placebo-controlled study when treating localized pelvic cancer.

Authors:  R Henriksson; L Franzén; B Littbrand
Journal:  Am J Med       Date:  1991-08-08       Impact factor: 4.965

5.  Association of tumor differentiation with caffeine and coffee intake in women with breast cancer.

Authors:  J Pozner; A E Papatestas; R Fagerstrom; I Schwartz; J Saevitz; M Feinberg; A H Aufses
Journal:  Surgery       Date:  1986-09       Impact factor: 3.982

6.  Vitamin B6 responsive growth of human tumors.

Authors:  H P Fortmeyer; C Timm; U Blum; H J Wenisch; H Förster
Journal:  Anticancer Res       Date:  1988 Jul-Aug       Impact factor: 2.480

7.  Vitamin K3 inhibition of malignant murine cell growth and human tumor colony formation.

Authors:  R T Chlebowski; M Dietrich; S Akman; J B Block
Journal:  Cancer Treat Rep       Date:  1985-05

8.  Potentiation of hydroxyurea cytotoxicity by iron-chelating agent in murine tumor models in vitro.

Authors:  K Satyamoorthy; M P Chitnis; S G Pradhan
Journal:  Cancer Drug Deliv       Date:  1986

9.  Enhancement of semustine-induced cytotoxicity by chlorpromazine and caffeine in a human melanoma xenograft.

Authors:  R Osieka; P Glatte; R Pannenbäcker; C G Schmidt
Journal:  Cancer Treat Rep       Date:  1986-10

10.  Enhanced antitumor effects of bleomycin and moderate hyperthermia by additional use of ethanol.

Authors:  W Takiyama; T Hirai; Y Miyoshi; T Yoshihara; T Hattori
Journal:  Jpn J Surg       Date:  1984-05
View more
  2 in total

Review 1.  Effects of food on the clinical pharmacokinetics of anticancer agents: underlying mechanisms and implications for oral chemotherapy.

Authors:  Brahma N Singh; Bimal K Malhotra
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 2.  Pharmacokinetic drug interactions with anticancer drugs.

Authors:  P M Loadman; M C Bibby
Journal:  Clin Pharmacokinet       Date:  1994-06       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.